Testing the efficacy of a couple-focused, tailored eHealth intervention for symptom self-management among men with prostate cancer and their partners: the study protocol.
Caregiver
Coping
Health behavior
Prostate cancer
Quality of life
Randomized clinical trial
Social support
Stress
Symptom management
eHealth
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
04 Jan 2022
04 Jan 2022
Historique:
received:
31
07
2021
accepted:
17
12
2021
entrez:
5
1
2022
pubmed:
6
1
2022
medline:
7
1
2022
Statut:
epublish
Résumé
Men with localized prostate cancer often experience urinary, sexual, bowel, and hormonal symptoms; general distress; pain; fatigue; and sleep disturbance. For men in an intimate relationship, these symptoms disrupt couples' relationships and intimacy. The symptoms also reduce quality of life for both men and their partners, who are often their primary caregivers. Management of the negative effects of cancer and its treatment is a significantly under-addressed supportive care need for these men and their intimate partners. To address these unmet supportive care needs, our interdisciplinary team developed and pilot tested the usability and feasibility of an evidence-based, couple-focused, tailored eHealth intervention, "Prostate Cancer Education & Resources for Couples" (PERC). Based on the adapted stress and coping theoretical framework and developed with stakeholder involvement, PERC aims to improve quality of life for both men and their partners by enhancing their positive appraisals, self-efficacy, social support, and healthy behaviors for symptom management. We will test the efficacy of PERC using a population-based, geographically and demographically diverse cohort in a randomized controlled trial. Primary aim: Assess if patients and partners receiving PERC will report greater improvement in their cancer-related quality of life scores than those in the control group (usual care plus the National Cancer Institute prostate cancer website) at 4, 8, and 12 months post-baseline. Secondary aim: Test if patients and partners in PERC will report significantly more positive appraisals and higher levels of coping resources at follow-ups than those in the control group. Exploratory aim: Determine if patient race and ethnicity, education, type of treatment, or couples' relationship quality moderate the effects of PERC on patient and partner QOL at follow-ups. This study will provide a novel model for self-managing chronic illness symptoms that impact couples' relationships, intimacy, and quality of life. It addresses the National Institute of Nursing Research's goal to develop and test new strategies for symptom self-management to help patients and caregivers better manage their illness and improve quality of life. It also responds to calls for programs from the Institute of Medicine and American Cancer Society to address treatment-related effects and improve survivors' QOL. CT.gov NCT03489057.
Sections du résumé
BACKGROUND
BACKGROUND
Men with localized prostate cancer often experience urinary, sexual, bowel, and hormonal symptoms; general distress; pain; fatigue; and sleep disturbance. For men in an intimate relationship, these symptoms disrupt couples' relationships and intimacy. The symptoms also reduce quality of life for both men and their partners, who are often their primary caregivers. Management of the negative effects of cancer and its treatment is a significantly under-addressed supportive care need for these men and their intimate partners. To address these unmet supportive care needs, our interdisciplinary team developed and pilot tested the usability and feasibility of an evidence-based, couple-focused, tailored eHealth intervention, "Prostate Cancer Education & Resources for Couples" (PERC). Based on the adapted stress and coping theoretical framework and developed with stakeholder involvement, PERC aims to improve quality of life for both men and their partners by enhancing their positive appraisals, self-efficacy, social support, and healthy behaviors for symptom management.
METHODS
METHODS
We will test the efficacy of PERC using a population-based, geographically and demographically diverse cohort in a randomized controlled trial. Primary aim: Assess if patients and partners receiving PERC will report greater improvement in their cancer-related quality of life scores than those in the control group (usual care plus the National Cancer Institute prostate cancer website) at 4, 8, and 12 months post-baseline. Secondary aim: Test if patients and partners in PERC will report significantly more positive appraisals and higher levels of coping resources at follow-ups than those in the control group. Exploratory aim: Determine if patient race and ethnicity, education, type of treatment, or couples' relationship quality moderate the effects of PERC on patient and partner QOL at follow-ups.
DISCUSSION
CONCLUSIONS
This study will provide a novel model for self-managing chronic illness symptoms that impact couples' relationships, intimacy, and quality of life. It addresses the National Institute of Nursing Research's goal to develop and test new strategies for symptom self-management to help patients and caregivers better manage their illness and improve quality of life. It also responds to calls for programs from the Institute of Medicine and American Cancer Society to address treatment-related effects and improve survivors' QOL.
TRIAL REGISTRATION
BACKGROUND
CT.gov NCT03489057.
Identifiants
pubmed: 34983621
doi: 10.1186/s13063-021-05948-5
pii: 10.1186/s13063-021-05948-5
pmc: PMC8725423
doi:
Banques de données
ClinicalTrials.gov
['NCT03489057']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12Subventions
Organisme : NINR NIH HHS
ID : R01NR016990
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Curr Hypertens Rev. 2015;11(2):91-9
pubmed: 25921545
BJU Int. 2014 Dec;114(6b):E74-E81
pubmed: 24588845
J Psychosoc Oncol. 2010;28(5):490-510
pubmed: 20730661
Cancer. 2014 May 1;120(9):1290-314
pubmed: 24343171
Cancer. 2007 Dec 15;110(12):2809-18
pubmed: 17999405
Cancer Nurs. 2013 May-Jun;36(3):E7-E14
pubmed: 22565105
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41
pubmed: 22700443
J Clin Oncol. 2007 Sep 20;25(27):4171-7
pubmed: 17635953
Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3640-3649
pubmed: 26853923
Qual Life Res. 2020 Aug;29(8):2241-2252
pubmed: 32246432
J Clin Oncol. 2002 Oct 1;20(19):4050-64
pubmed: 12351603
J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42
pubmed: 22835388
Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
J Pain Symptom Manage. 2013 May;45(5):811-21
pubmed: 23017624
JAMA. 2011 Dec 7;306(21):2359-66
pubmed: 22147380
Patient Educ Couns. 2010 Dec;81 Suppl:S54-62
pubmed: 20934297
Nurs Res. 2011 Nov-Dec;60(6):430-5
pubmed: 22048559
BMC Public Health. 2014 Jul 21;14:734
pubmed: 25042423
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007566
pubmed: 22895961
CA Cancer J Clin. 2014 Jul-Aug;64(4):225-49
pubmed: 24916760
BJU Int. 2012 Dec;110(11):1690-5
pubmed: 22502770
Qual Life Res. 2011 Apr;20(3):371-81
pubmed: 20927648
Urology. 1997 Dec;50(6):920-8
pubmed: 9426724
Res Nurs Health. 2006 Jun;29(3):199-211
pubmed: 16676337
World J Urol. 2015 Sep;33(9):1281-9
pubmed: 25387877
J Clin Oncol. 2011 Feb 1;29(4):362-8
pubmed: 21149658
Qual Life Res. 2014 Oct;23(8):2309-17
pubmed: 24609438
Eur Urol. 2014 May;65(5):887-94
pubmed: 23962747
Ann Behav Med. 2008 Oct;36(2):117-28
pubmed: 18830672
Support Care Cancer. 2009 May;17(5):509-17
pubmed: 18719947
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
J Nutr Sci. 2013 Apr 29;2:e15
pubmed: 25191563
Rev Urol. 2013;15(4):161-77
pubmed: 24659913
BMC Urol. 2014 Jul 30;14:56
pubmed: 25073798
Med Sci Sports Exerc. 2011 Nov;43(11):2127-33
pubmed: 21448077
Oncol Nurs Forum. 2015 Mar;42(2):183-92
pubmed: 25806885
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Patient Educ Couns. 2011 Aug;84(2):200-7
pubmed: 20702055
Patient Educ Couns. 2015 May;98(5):633-9
pubmed: 25648280
Nutr Hosp. 2014 Oct 31;31(3):1012-9
pubmed: 25726188
Psychol Bull. 2008 Jan;134(1):1-30
pubmed: 18193993
Health Psychol. 2004 Sep;23(5):443-51
pubmed: 15367063
J Am Diet Assoc. 2007 Feb;107(2):246-55
pubmed: 17258961
Br J Cancer. 2013 May 14;108(9):1784-9
pubmed: 23612450
Semin Oncol Nurs. 2011 Nov;27(4):300-8
pubmed: 22018409